Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOCOVID Study of voclosporin in SARS-CoV-2 positive kidney transplant recipients
2020-001467-82Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of voclosporin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Reduction in SARS-CoV-2 viral load over 28 days. Started Apr 2020; status: completed.
02
Drugs
voclosporin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001467-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001467-82.